Low-Grade Serous Ovarian Cancer — Rapid Case Review: Microlearning Activity 2
Featuring perspectives from Dr Rachel N Grisham, including the following topics:
- Case: A woman in her early 40s with recurrent low-grade serous ovarian cancer (LGSOC) and prior treatment with a MEK inhibitor receives avutometinib/defactinib on the RAMP 301 trial (0:00)
- Case: A woman in her early 70s with recurrent KRAS-mutated LGSOC receives avutometinib/defactinib and develops muscle weakness (10:03)
- Case: A woman in her late 70s with KRAS-mutated recurrent LGSOC develops congestive heart failure on trametinib and then receives avutometinib/defactinib (16:15)
- Case: A woman in her mid 60s with recurrent BRAF V600E LGSOC has concerns about side effects and receives single-agent dabrafenib (19:49)
You May Also Like

Eye On The Sky
Vermont Public

Мослекторий
Москва 24

Arroe Collins Forest Stories
Arroe Collins

Science & Futurism with Isaac Arthur
Isaac Arthur

The Grave Talks | Haunted, Paranormal & Supernatural
Ghost Stores, Haunted, Paranormal & Supernatural Stories

Farm Small Farm Smart Daily
The Modern Grower Podcast Network

The 365 Days of Astronomy
365DaysOfAstronomy.org

Real Ghost Stories Online
Real Ghost Stories Online | Paranormal, Supernatural & Horror Radio

Stuff To Blow Your Mind
iHeartPodcasts

The Best of Coast to Coast AM
iHeartPodcasts and Coast to Coast AM
Community discussion